https://www.selleckchem.com/pr....oducts/5-cholesten-3
CAM patient mortality was worse compared with CNAM patients (log-rank test, p less then 0.01). CONCLUSIONS Among IIM patients with malignancy, common sites of malignancy were different between the CAM and CNAM groups, and patients with CAM had poor prognosis compared with CNAM patients.Key Points• The malignancies commonly occurred in incident idiopathic inflammatory myopathy (IIM) patients, especially within 1 year before and after the initial IIM diagnosis.• Patients with malignancy had poor survival compared with
Me gusta
Comentario
Compartir
